Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Bobulsky Susan. Director active across 1 company, notably Adaptive Biotechnologies Corp. In total, 13 reports have been published. Breakdown: 0 buy · 9 sells. Total volume traded: €869k. History available since 4 March 2024. The latest transaction was disclosed on 15 September 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Bobulsky Susan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
1,195 shares@ US$27.00Common StockSEC:0001820885-26-000023:0
3,000 shares@ US$25.000.0018% mcap7.6% of flowCommon StockSEC:0001820885-26-000020:0
1,299 shares@ US$24.000.0009% mcap3.5% of flowCommon StockSEC:0001820885-26-000018:0
5,000 shares@ US$23.000.0031% mcap13.2% of flowCommon StockSEC:0001820885-26-000016:0
487 shares@ US$22.000.0003% mcap5.0% of flowCommon StockSEC:0001820885-26-000014:0
5,000 sharesCommon StockSEC:0001820885-26-000012:0
5,000 sharesCommon StockSEC:0001820885-26-000010:0
11,000 shares@ US$18.000.0055% mcap95.0% of flowCommon StockSEC:0001820885-26-000008:0
41,338 shares@ US$13.1771.3% of flowCommon StockSEC:0001820885-26-000004:0
59,375 shares0Common StockSEC:0001820885-26-000002:0
119,971 shares0Common StockSEC:0001062993-25-004817:0
5,000 shares@ US$1.98100.0% of flowCommon StockSEC:0001062993-24-017564:0
132,979 shares0Common StockSEC:0001062993-24-005757:0
About Bobulsky Susan
Susan Bobulsky is a declarant linked to Adaptive Biotechnologies Corp, where she holds the role of Chief Commercial Officer, MRD. She has made 11 filings in total, and across the 11 sampled filings, the transactions are all sales, for EUR 776225 between 2024-03-06 and 2026-08-03.